UBS initiated coverage of Crown with a rating of Buy and set a new price target of $112.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/13/2025 | $109.00 → $105.00 | Equal-Weight → Overweight | Morgan Stanley |
| 4/16/2024 | $85.00 → $90.00 | Neutral → Outperform | Robert W. Baird |
| 3/27/2024 | $100.00 → $88.00 | Buy → Hold | Truist |
| 3/18/2024 | $87.00 | Equal-Weight | Morgan Stanley |
| 3/1/2024 | $102.00 | Outperform | Wolfe Research |
| 2/7/2024 | $85.00 | Neutral → Overweight | JP Morgan |
| 1/16/2024 | $112.00 | Buy | UBS |
| 1/4/2023 | $80.00 | Outperform → Neutral | Robert W. Baird |
Morgan Stanley upgraded Crown from Equal-Weight to Overweight and set a new price target of $105.00 from $109.00 previously
Robert W. Baird upgraded Crown from Neutral to Outperform and set a new price target of $90.00 from $85.00 previously
Truist downgraded Crown from Buy to Hold and set a new price target of $88.00 from $100.00 previously